These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27626477)

  • 1. Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance.
    Mendonça ML; Batista SL; Nogueira-Barbosa MH; Salmon CE; Paula FJ
    Clinics (Sao Paulo); 2016 Aug; 71(8):464-9. PubMed ID: 27626477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism.
    Ayturk S; Gursoy A; Bascil Tutuncu N; Ertugrul DT; Guvener Demirag N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4260-3. PubMed ID: 16895964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
    Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.
    Kaji H; Yamauchi M; Chihara K; Sugimoto T
    Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism.
    Gianotti L; Piovesan A; Croce CG; Pellegrino M; Baffoni C; Cesario F; Visconti G; Borretta G; Tassone F
    Calcif Tissue Int; 2011 Mar; 88(3):231-7. PubMed ID: 21207016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
    Thorsen K; Kristoffersson AO; Lorentzon RP
    Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
    Valdemarsson S; Lindergård B; Tibblin S; Bergenfelz A
    J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow fat contributes to insulin sensitivity and adiponectin secretion in premenopausal women.
    Ermetici F; Briganti S; Delnevo A; Cannaò P; Leo GD; Benedini S; Terruzzi I; Sardanelli F; Luzi L
    Endocrine; 2018 Feb; 59(2):410-418. PubMed ID: 28624865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.
    Dalemo S; Eggertsen R; Hjerpe P; Almqvist EG; Boström KB
    Scand J Prim Health Care; 2018 Jun; 36(2):198-206. PubMed ID: 29623754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical variables associated with bone density in patients with primary hyperparathyroidism.
    Bergenfelz A; Lindergård B; Ahrén B
    Eur J Surg; 1992 Sep; 158(9):473-6. PubMed ID: 1358213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance negatively affects bone quality not quantity: the relationship between bone and adipose tissue.
    de Araújo IM; Parreiras-E-Silva LT; Carvalho AL; Elias J; Salmon CEG; de Paula FJA
    Osteoporos Int; 2020 Jun; 31(6):1125-1133. PubMed ID: 32108240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
    Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bone mass and metabolism after surgery for primary hyperparathyroidism.
    Garton M; Martin J; Stewart A; Krukowski Z; Matheson N; Robins S; Loveridge N; Reid D
    Clin Endocrinol (Oxf); 1995 May; 42(5):493-500. PubMed ID: 7621568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones.
    Abe Y; Ejima E; Fujiyama K; Kiriyama T; Ide A; Sera N; Tominaga T; Ashizawa K; Yokoyama N; Eguchi K
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):203-9. PubMed ID: 10671948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism.
    Gianotti L; Tassone F; Baffoni C; Pellegrino M; Cassibba S; Castellano E; Magro G; Cesario F; Visconti G; Borretta G
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):350-5. PubMed ID: 24750210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study.
    Ardawi MS; Al-Sibiany AM; Bakhsh TM; Rouzi AA; Qari MH
    Osteoporos Int; 2012 Jun; 23(6):1789-97. PubMed ID: 22041864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of parathyroidectomy on osteopontin and undercarboxylated osteocalcin in patients with primary hyperparathyroidism.
    Maser RE; Lenhard MJ; Pohlig RT; Balagopal PB; Abdel-Misih R
    Endocr Res; 2018 Feb; 43(1):21-28. PubMed ID: 28937873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.